Dr. Deirdre Little, a pediatrician in Australia, was the first one to sound the alarm over the HPV vaccine causing premature menopause when she observed it in one of her 16 year old patients in 2012. Dr. Little published a paper in the British Medical Journal warning that the premature menopause of a healthy 16-year-old girl may be linked to the Gardasil vaccination. You can watch an 8 minute interview with Dr. Little here:
Now, a new study has just been recently published in the American Journal of Reproductive Immunology documenting three more cases of “Primary Ovarian Failure,” where three young girls stopped having periods and showed signs of menopause. The study confirms Dr. Little’s experience, and was conducted in Israel and Italy. The authors concluded:
We documented here the evidence of the potential of the HPV vaccine to trigger a life-disabling autoimmune condition. The increasing number of similar reports of post HPV vaccine-linked autoimmunity and the uncertainty of long-term clinical benefits of HPV vaccination are a matter of public health that warrants further rigorous inquiry.
Countries Outside of the U.S. are Discovering the Dangers of the HPV Vaccine
It is not surprising that this study was not conducted in the U.S. As Dr. Deirdre Little observed back in 2012, the Gardasil manufacturer did not conduct studies on ovarian effects of the vaccine or any studies regarding ongoing fertility effects. Gardasil has become a huge financial success, and is one of the most lucrative vaccines in the market.
But the side effects to Gardasil, which are more than just Primary Ovarian Failure, are becoming more and more known as sales of Gardasil might be slowing down, or at least not increasing as fast as the manufacturers would like them to. In countries where the vaccine is not produced, studies like the one referenced above are being conducted since it is apparent they will probably not be done in the U.S. The health ministry of Japan recently issued a nationwide notice that HPV vaccinations should no longer be recommended for girls aged 12 to 16 because so many adverse reactions have been reported.
Why Aren’t the Dangers of the HPV Vaccine Being Investigated in the U.S.?
So while other countries are beginning to put the brakes on the HPV vaccine and doing their own research, what is happening in the U.S.? The mainstream media, apparently simply reprinting press releases directly from the pharmaceutical companies, is actually portraying the HPV vaccines as one of the safest vaccines around, and lamenting the fact that more girls are not getting it! Here are some examples:
Doctors say HPV vaccine is safe and “grossly underutilized” - Need for vaccine ‘not understood’ by parents - from Medical News Today, July 27, 2013
HPV vaccination rate stalls. ‘We’re dropping the ball,’ CDC says - ”The vaccine is safe and effective,” Schuchat said. “We need doctors to recommend it and deliver it.” - from Los Angeles Times, July 25, 2013
Parents’ Worries About HPV Vaccine on the Rise: Study – from U.S. News and World Report, March 18, 2013 Quote:
Both Darden and Cunningham said it’s puzzling that parents’ safety worries about the HPV vaccine would grow so much, so fast. It’s not clear from the study, but Cunningham said he suspects many parents get misinformation online.
“There’s a lot of unreliable vaccine information out there,” he said. As for safety, he suggested that parents with concerns go to reliable online sites, like the CDC website, and talk with their child’s doctor.
As for the Israeli/Italian peer-reviewed study which is indexed on PubMed, the NIH website, linking HPV vaccines to causing girls to go into premature menopause? Not a peep in the U.S. mainstream media….
Earlier this year, Jeffry John Aufderheide of Vactruth.org revealed that Merck, the manufacturer of Gradasil, paid out over $18 million in speaking fees to doctors to promote their drugs, including Gardasil. So are medical doctors in the U.S. really the best source of knowledge on the side effects of a vaccine they are paid to promote??
As far as trusting the CDC website: Julie Gerberding was in charge of the CDC from 2002 to 2009, which includes the years the FDA approved Gardasil as a vaccine. Soon after she took over the CDC, she reportedly completely overhauled the agency’s organizational structure, and many of the CDC’s senior scientists and leaders either left or announced plans to leave. Some have claimed that almost all of the replacements Julie Gerberding appointed had ties to the vaccine industry.
Gerberding resigned from the CDC on January 20, 2009, and is now the president of Merck’s Vaccine division, a $5 billion dollar a year operation, and the supplier of the largest number of vaccines the CDC recommends (article here).
Do you think this might be one reason why the U.S. is not investigating or even reporting the negative side effects of the HPV vaccine?
Then there is the issue of how much money the government makes off of royalties from the HPV vaccines. In November 2010, Dr. Eric Suba submitted a Freedom of Information Request to the Office of Government Information Services to discover the amount of money the U.S government earns from Merck’s sale of Gardasil. But apparently the government is immune from revealing those figures, as you can read for yourself the response Dr. Suba received here.
So not only is the CDC not publishing the dangers of the HPV vaccine, but two years ago they recommended young boys get the vaccine also, and there is a push on now to start giving it to infants. In the state of California, a bill funded by Gardasil producer Merck was passed allowing schools to administer the HPV vaccine to girls without their parent’s consent or knowledge.
In the United States, there are several websites and Facebook pages that tell the stories of young women who have suffered from the effects of the HPV vaccine, or even worse, have died. You won’t likely get this information from your doctor, and you will certainly not find it on government websites. Here are a few:
Post a Comment
EmoticonClick to see the code!
To insert emoticon you must added at least one space before the code.